| Financial Year |
March 31 2023 |
| Monetary Funds |
13,038,856,527.28 |
| Held-for-trading Financial Assets |
173,378,039.88 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,173,220,367.86 |
| Advances to Suppliers |
707,868,317.92 |
| Other Receivables |
505,490,991.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,774,739,941.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
204,202,476.47 |
| Total Current Assets |
23,599,845,887.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
160,001,615.94 |
| Investment Properties |
815,626,916.72 |
| Fixed Assetes |
3,086,680,709.41 |
| Under-construction Projects |
31,687,447.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
880,898,841.51 |
| R&D expenses |
-- |
| Goodwill |
732,326,477.95 |
| Long-Term Deferred and Prepaid Expenses |
309,419,374.11 |
| Deferred Income Tax Assets |
646,490,129.12 |
| Other Non-Current Assets |
11,907,865.35 |
| Sub-Total of Non-Current Assets |
8,283,024,998.84 |
| Total Assets |
31,882,870,886.64 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,253,310,000.00 |
| Accounts Payable |
7,173,871,874.87 |
| Accounts Received In Advance |
3,931,350.00 |
| Employee Compensation Payable |
320,842,941.98 |
| Taxes Payable |
623,667,226.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,920,510,551.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
582,028,728.15 |
| Other Current Liabilities |
97,938,350.42 |
| Sub-Total of Current Liabilities |
12,796,067,728.68 |
| Long-term Loans |
-- |
| Bonds Payable |
2,815,014,174.62 |
| Long-Term Accounts Payable |
184,243,334.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
111,304,456.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,777,272,316.82 |
| Total Liabilities |
16,573,340,045.50 |
| Paid-In Capital(Or Share Stock) |
994,966,721.00 |
| Capital Surplus |
563,229,903.79 |
| Surplus Reserve |
2,424,890,515.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
11,033,012,512.80 |
| Minority Stockholder's Interest |
-87,929,064.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,397,459,905.68 |
| Owner's Equity（Stockholder's Equity） |
15,309,530,841.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,882,870,886.64 |
